XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.100
0.00 (0.00%)
At close: Mar 13, 2026
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 19.87 million as of March 13, 2026. Its market cap has decreased by -71.71% in one year.
Market Cap
19.87M
Enterprise Value
19.29M
Revenue
3.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 19.87M, a decrease of -97.53%. That is a compound annual growth rate of -16.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 19.87M | -12.50% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 499.87M |
| Geffen Residence & Renewal | 267.57M |
| Matricelf | 142.71M |
| Clal Biotechnology Industries | 45.33M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 29.72M |
| Evogene | 22.34M |
| Purple Biotech | 18.58M |